H-ISAC Report: Hacking Healthcare - TLP White, February 4, 2020

In this edition of Hacking Healthcare, we begin by examining a milestone in the integration of
Artificial Intelligence/Machine Learning (AI/ML) into drug treatment development. Next, we
brief you on new developments in Huawei’s ongoing saga to avoid a European ban and what it
may mean for EU-US relations. Lastly, in continuing our coverage of the cyber insurance
market, we look at what a new decision in favor of an email fraud victim might mean for the
still evolving market.

In this edition:

• AI Takes Prominent Role in Drug Development
• Europe and the UK Diverge with the US on Huawei
• AIG Forced to Cover Cyber Related Losses